thymoquinone has been researched along with Carcinoma, Ehrlich Tumor in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Amin, DM; Arafa, MH; Atteia, HH; Mohammad, NS; Sakr, AT | 1 |
Abo-Elmatty, DM; Mehanna, ET; Mesbah, NM; Mosalam, EM; Zidan, AA | 1 |
Ghanem, HB | 1 |
Ebeid, EM; El-Ashmawy, NE; Khedr, EG; Mosalam, EM; Salem, ML; Zidan, AA | 1 |
Aksu, H; Çakır, M; Canatan, H; İskender, B; İzgi, K; Kurt, B; Şakalar, Ç; Sezen, S; Turan, A | 1 |
al-Bekairi, AM; al-Gharably, NM; al-Rikabi, AC; al-Shabanah, OA; Badary, OA; Nagi, MN | 1 |
6 other study(ies) available for thymoquinone and Carcinoma, Ehrlich Tumor
Article | Year |
---|---|
Thymoquinone upregulates miR-125a-5p, attenuates STAT3 activation, and potentiates doxorubicin antitumor activity in murine solid Ehrlich carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Benzoquinones; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Doxorubicin; Mice; MicroRNAs; STAT3 Transcription Factor; Up-Regulation | 2021 |
Thymoquinone and pentoxifylline enhance the chemotherapeutic effect of cisplatin by targeting Notch signaling pathway in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Carcinoma, Ehrlich Tumor; Cisplatin; Female; Mice; Pentoxifylline; Receptor, Notch1; Receptors, Notch; Signal Transduction | 2020 |
Impact of zinc oxide nanoparticles and thymoquinone in Ehrlich ascites carcinoma induced in mice.
Topics: Animals; Benzoquinones; Carcinoma, Ehrlich Tumor; Female; Gene Expression Regulation, Neoplastic; Mice; Nanoparticles; Neoplasm Proteins; Zinc Oxide | 2021 |
Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
Topics: Acetylglucosamine; Animals; Antibiotics, Antineoplastic; Benzoquinones; Carcinoma, Ehrlich Tumor; Chemotherapy, Adjuvant; Creatine Kinase; Creatine Kinase, MB Form; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Genes, p53; L-Lactate Dehydrogenase; Malondialdehyde; Mice; Microscopy, Electron, Transmission; Myocardium; Nanostructures; Proto-Oncogene Proteins c-bcl-2; Tumor Burden | 2017 |
The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Neoplasm Transplantation; Paclitaxel; Triple Negative Breast Neoplasms; Tumor Burden | 2016 |
Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.
Topics: Animals; Antibiotics, Antineoplastic; Benzoquinones; Carcinoma, Ehrlich Tumor; Creatine Kinase; Disease Models, Animal; Doxorubicin; Drug Interactions; Female; Heart Diseases; Mice; Myocardium | 1998 |